Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA OTC labeling rule crowds out "important consumer information" -- CTFA.

This article was originally published in The Rose Sheet

Executive Summary

FDA OTC LABEL RULE WOULD EXCLUDE "IMPORTANT CONSUMER INFORMATION," CTFA said, including claims such as non-comedo-genic, PABA free and fragrance free. Addressing FDA's Nonprescription Drugs Advisory Committee on the issue of FDA's proposed OTC label reform rule July 14, Cosmetic, Toiletry & Fragrance Association Assistant General Counsel Stephen Gettings maintained that "other important consumer information that's not required by any government agency," but is included on cosmetics packaging, is not accounted for under FDA's proposed labeling reg. These claims would be crowded out of labeling due to the amount of information required within a rigid template under the agency's proposal, CTFA asserted.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts